SAN FRANCISCO--(BUSINESS WIRE)--Encellin, a biotechnology company developing a cell encapsulation platform with an initial focus on Type 1 Diabetes (T1D), announced the closing of a $9.9M financing ...
Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel ...
LAS VEGAS, Dec. 16, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging biotechnology company focused on developing cell-based therapies for diabetes ...
Morning Overview on MSN
New synthetic-cell system boosts flexibility in mimicking cellular functions
Researchers have built a synthetic-cell platform that can be chemically adjusted in real time, sidestepping a long-standing ...
CiQUS researchers introduces an innovative chemical strategy to create biomimetic structures with greater efficiency. The design of more versatile and controllable synthetic cells could unlock new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results